Session Details

Wednesday Posters - Neuropsychiatry / Cognitive Neuropsychiatry

Wednesday, 11 February 2004 16:00 -17:00

Hall 5, Exhibition Halls

Posters will be on display from Tuesday, 10 February until Thursday, 12 February.

Presenters will be in attendance to discuss their posters in this topic between 16:00-17:00 on Wednesday, 11 February.

Deficiency of theory of mind in patients with remitted mood disorder
  • Dr Yumiko Inoue, University of Yamanashi, Japan
    • Deficiency of theory of mind in patients with remitted schizophrenia
  • Dr Yumiko Inoue, University of Yamanashi, Japan
    • Effect of Olanzapine vs. placebo on the neuropsychological status of prodromal subjects
  • Keith A Hawkins, Yale University School of Medicine, United States
    • Pituitary volume in people at ultra high-risk for psychosis: Larger volume predicts transition to affective psychosis
  • Ms Belinda Garner, Mental Health Research Institute & Melbourne Neuropsychiatry Centre, University of Melbourne, Australia
    • Is cognitive improvement with antipsychotic treatment pseudospecific?
  • Ms Eva M Marquez, Eli Lilly and Company, United States
    • Functional outcomes and characteristics of Olanzapine cognitive super-responders
  • Dr Richard C Mohs, Eli Lilly and Company, United States
    • Information processing impairment in criminal and non-criminal schizophrenic patients
  • Dr Semion Kertzman, Beer-Yakov Mental Health Center and Anima Scan LTD, Ashdod, Israel
    • Neuropsychological findings in patients with systemic lupus erythematosus
  • Okihiko Aihara, Graduate School of Tokyo Medical & Dental University, Japan
    • Changes in EEG and autonomic nervous activity during meditation and their association with personality traits
  • Masao Omori, Fukui Medical University, Japan
  • Yuji Wada, Fukui Medical University, Japan
    • Estrogen deficiency and cognitive deficit in women of reproductive age. A pilot study
  • Kari A Leiknes, Rikshospitalet HF University Hospital, Oslo, Norway
    • A case report: Manifested by catatonic schizophrenia
  • Meltem Efe Sevim, Turkey
    • Objective measurement of cognitive endurance and capacity after vascular disorders in the brain
  • Stud Anders Starmark, Sahlgrenska Academy at Göteborg University, Sweden
    • The difference of Spacial working memory characteristics in Alzheimer's disease and erderly depressed patients
  • Yoshihisa Hatakeyama, Sapporo Medical University, Japan
  • Takahiro Tajima, Sapporo Medical University School of Medicine, Japan
  • Toshikazu Saito, Sapporo Medical University, Japan
  • Shinji Murakami, Sapporo Medical University, Japan
    • Neurological and psychiatrical symptoms in progressive supranuclear palsy(PSP). Case report
  • Kaire Aadamsoo, North Estonian Regional Hospital, Estonia
  • Dr Toomas Toomsoo, East Tallinn Central Hospital, Estonia